MORE IMPAIRED DIASTOLIC FUNCTION OF LIGHT CHAIN AMYLOIDOSIS CONTRIBUTE TO POOR PROGNOSIS COMPARED WITH TRANSTHYRETIN AMYLOIDOSIS: RESULT FROM LONGITUDINAL STUDY OF BIOPSY-PROVEN CARDIAC AMYLOIDOSIS
Mari Sakamoto(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Makoto Amaki(National Cerebral and Cardiovascular Center), Masafumi Kitakaze(Hanwa Memorial Hospital), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Yasuo Sugano(keiyu Hospital), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Akira Funada(National Cerebral and Cardiovascular Center)
Cited by 2
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363